601 related articles for article (PubMed ID: 16740693)
21. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
22. The necessity of a human epigenome project.
Esteller M
Carcinogenesis; 2006 Jun; 27(6):1121-5. PubMed ID: 16699174
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs.
Baker EK; Johnstone RW; Zalcberg JR; El-Osta A
Oncogene; 2005 Dec; 24(54):8061-75. PubMed ID: 16091741
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells.
Ji W; Yang L; Yu L; Yuan J; Hu D; Zhang W; Yang J; Pang Y; Li W; Lu J; Fu J; Chen J; Lin Z; Chen W; Zhuang Z
Carcinogenesis; 2008 Jun; 29(6):1267-75. PubMed ID: 18204074
[TBL] [Abstract][Full Text] [Related]
25. Chromatin assembly factor 1 interacts with histone H3 methylated at lysine 79 in the processes of epigenetic silencing and DNA repair.
Zhou H; Madden BJ; Muddiman DC; Zhang Z
Biochemistry; 2006 Mar; 45(9):2852-61. PubMed ID: 16503640
[TBL] [Abstract][Full Text] [Related]
26. Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin.
Baylin SB
Novartis Found Symp; 2004; 259():226-33; discussion 234-7, 285-8. PubMed ID: 15171257
[TBL] [Abstract][Full Text] [Related]
27. Histone methylation is a critical regulator of the abnormal expression of POU5F1 and RASSF1A in testis cancer cell lines.
Lambrot R; Kimmins S
Int J Androl; 2011 Apr; 34(2):110-23. PubMed ID: 20497257
[TBL] [Abstract][Full Text] [Related]
28. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors.
Fraga MF; Herranz M; Espada J; Ballestar E; Paz MF; Ropero S; Erkek E; Bozdogan O; Peinado H; Niveleau A; Mao JH; Balmain A; Cano A; Esteller M
Cancer Res; 2004 Aug; 64(16):5527-34. PubMed ID: 15313885
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
30. Distinct dynamics and distribution of histone methyl-lysine derivatives in mouse development.
Biron VL; McManus KJ; Hu N; Hendzel MJ; Underhill DA
Dev Biol; 2004 Dec; 276(2):337-51. PubMed ID: 15581869
[TBL] [Abstract][Full Text] [Related]
31. Halogenated thymidine analogues restore the expression of silenced genes without demethylation.
Fan J; Kodama E; Koh Y; Nakao M; Matsuoka M
Cancer Res; 2005 Aug; 65(15):6927-33. PubMed ID: 16061677
[TBL] [Abstract][Full Text] [Related]
32. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of HSulf-1 in ovarian cancer:implications in chemoresistance.
Staub J; Chien J; Pan Y; Qian X; Narita K; Aletti G; Scheerer M; Roberts LR; Molina J; Shridhar V
Oncogene; 2007 Jul; 26(34):4969-78. PubMed ID: 17310998
[TBL] [Abstract][Full Text] [Related]
34. Suppression of viral gene expression in bovine leukemia virus-associated B-cell malignancy: interplay of epigenetic modifications leading to chromatin with a repressive histone code.
Merimi M; Klener P; Szynal M; Cleuter Y; Kerkhofs P; Burny A; Martiat P; Van den Broeke A
J Virol; 2007 Jun; 81(11):5929-39. PubMed ID: 17392371
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
Li LC; Carroll PR; Dahiya R
J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic regulation of CIITA expression in human T-cells.
van Eggermond MC; Boom DR; Klous P; Schooten E; Marquez VE; Wierda RJ; Holling TM; van den Elsen PJ
Biochem Pharmacol; 2011 Nov; 82(10):1430-7. PubMed ID: 21664896
[TBL] [Abstract][Full Text] [Related]
37. Gene silencing by DNA methylation in haematological malignancies.
Boultwood J; Wainscoat JS
Br J Haematol; 2007 Jul; 138(1):3-11. PubMed ID: 17489980
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific and imprinted epigenetic modifications of the human NDN gene.
Lau JC; Hanel ML; Wevrick R
Nucleic Acids Res; 2004; 32(11):3376-82. PubMed ID: 15247330
[TBL] [Abstract][Full Text] [Related]
39. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
Dahl JA; Collas P
Stem Cells; 2007 Apr; 25(4):1037-46. PubMed ID: 17272500
[TBL] [Abstract][Full Text] [Related]
40. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
